The shares of South Jersey Industries, Inc. (NYSE:SJI) started off the last trading session with the price of $27.82 while closing the day with the price of $28.04. The shares of South Jersey Industries, Inc. (NYSE:SJI) Fell -0.04% with the Gain of 0.22 points.
The shares of South Jersey Industries, Inc. (NYSE:SJI) traded with the day volume of 1.73 Million shares whereas its average trading volume is 521.22 Million.
While analyzing the past performance of the stock we can see that the shares of South Jersey Industries, Inc. (NYSE:SJI) Gain 3.01% in the last week while rising 6.25% in the last month. Past quarter performance shows the red light with -12.84%. The semi-annual and annual performance shows -22.33% and -16.8% respectively.
Some critical values of the shares of South Jersey Industries, Inc. (NYSE:SJI) to be discussed here are: the beta which shows the value at 0.7 while Average True Range of South Jersey Industries, Inc. (NYSE:SJI) demonstrate the value at 0.68. The weekly and monthly volatility of the shares of South Jersey Industries, Inc. (NYSE:SJI) are indicated at 2.10% and 2.54%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 56.09.
While studying the financial position of the shares of South Jersey Industries, Inc. (NYSE:SJI), we can see that the Market capitalization of the company is at 2.23 Billion. The shares outstanding for the company is 79.58 Million and the shares float stands at 78.96 Million. The income of the company stand at -3400000 while the sales stand at 1.24 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at -0.04, Price to Earnings or P/E is at 0, Price to Sales P/S show the value of 1.8, the Return on Asset ROA stood at -0.001 and the Return on Equity ROE depicted at -0.003 while Return on Investment ROI is at 0.011.
Cymabay Therapeutics, Inc. (NASDAQ:CBAY)
Cymabay Therapeutics, Inc. (NASDAQ:CBAY) started its previous trading session at $12.9 and closed at $13.74 showing a Rise of 10.01 Percent.
The Company traded with an average Volume of 953.39 Million whereas, its Day Volume stood at 1.73 Million.
Looking at the performance of the stock, Cymabay Therapeutics, Inc. (NASDAQ:CBAY) Loss -8.34% in the last week in its shares price and 2.08% in the last month. Quarterly performance shows a green of 68.38 Percent while Semi-Annual and Annual performances shows a 95.17 and 223.29 percent respectively.
Beta for Cymabay Therapeutics, Inc. (NASDAQ:CBAY) stands at 1.83 while the ATR (average true range) is at 1.05. The Stock’s Weekly and Monthly Volatility is 8.74% and 6.96% respectively showing a RSI value of 51.63.
While studying the financial position of the shares of Cymabay Therapeutics, Inc. (NASDAQ:CBAY), we can see that the Market capitalization of the company is at 692.5 Million. The shares outstanding for the company is 50.4 Million and the shares float stands at 50.4 Million.
The Company generated an income of -29500000 and the sales of 4.8 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-1.01 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 144.27 respectively.
The Return on Assets stands at -0.646, ROE shows a value of -1.065 and ROI for Cymabay Therapeutics, Inc. (NASDAQ:CBAY) is -1.679 as of Trailing Twelve Months period.
